A detailed history of Price T Rowe Associates Inc transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 849,619 shares of ABOS stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
849,619
Previous 1,046,364 18.8%
Holding current value
$1.5 Million
Previous $2.53 Million 16.78%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.22 - $3.54 $436,773 - $696,477
-196,745 Reduced 18.8%
849,619 $2.11 Million
Q2 2024

Aug 14, 2024

SELL
$2.14 - $4.01 $111,091 - $208,167
-51,912 Reduced 4.73%
1,046,364 $2.53 Million
Q1 2024

May 15, 2024

BUY
$2.97 - $4.64 $3.26 Million - $5.1 Million
1,098,276 New
1,098,276 $4.45 Million

Others Institutions Holding ABOS

About Acumen Pharmaceuticals, Inc.


  • Ticker ABOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,503,100
  • Market Cap $71.7M
  • Description
  • Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...
More about ABOS
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.